Anouschka Ramsteijn

Ms. Anouschka Ramsteijn

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2023 in Trends in Parasitology
Verified
Journal Article
Open access
IGIsobel L. Gabain
Isobel L. Gabain
ARAnouschka Ramsteijn
Anouschka Ramsteijn
JWJoanne Webster
Joanne Webster
Globally, stunting affects approximately 149.2 million children under 5 years of age. The underlying aetiology and pathophysiological mechanisms leading to stunting remain elusive, and therefore few effective treatment and prevention strategies exist. Crucial evidence directly linking parasites to stunting is often lacking - in part due to the complex nature of stunting, as well as a lack of critical multidisciplinary research amongst key age groups. Here, based on available studies, we present potential mechanistic pathways by which parasitic infection of mother and/or infant may lead to childhood stunting. We highlight the need for future multidisciplinary longitudinal studies and clinical trials aimed at elucidating the most influential factors, and synergies therein, that can lead to stunting, and ultimately towards finding solutions to successfully mitigate against it.

23 January 2020 in Gut Microbes
Verified
Journal Article
Open access
ARAnouschka Ramsteijn
Anouschka Ramsteijn
EJEldin Jašarević
Eldin Jašarević
DHDanielle J Houwing
Danielle J Houwing
TBTracy L Bale
Tracy L Bale
JOJocelien Olivier
Jocelien Olivier
Up to 10% of women use selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy and postpartum. Recent evidence suggests that SSRIs are capable of altering the gut microbiota. However, the interaction between maternal depression and SSRI use on bacterial community composition and the availability of microbiota-derived metabolites during pregnancy and lactation is not clear. We studied this using a rat model relevant to depression, where adult females with a genetic vulnerability and stressed as pups show depressive-like behaviors. Throughout pregnancy and lactation, females received the SSRI fluoxetine or vehicle. High-resolution 16S ribosomal RNA marker gene sequencing and targeted metabolomic analysis were used to assess the fecal microbiome and metabolite availability, respectively. Not surprisingly, we found that pregnancy and lactation segregate in terms of fecal microbiome diversity and composition, accompanied by changes in metabolite availability. However, we also showed that fluoxetine treatment altered important features of this transition from pregnancy to lactation most clearly in previously stressed dams, with lower fecal amino acid concentrations. Amino acid concentrations, in turn, correlated negatively with the relative abundance of bacterial taxa such as Prevotella and Bacteroides. Our study demonstrates an important relationship between antidepressant use during the perinatal period and maternal fecal metabolite availability in a rat model relevant to depression, possibly through parallel changes in the gut microbiome. Since microbial metabolites contribute to homeostasis and development, insults to the maternal microbiome by SSRIs might have health consequences for mother and offspring.

31 August 2018 in Behavioural Brain Research
Verified
Journal Article
Open access
PDF file
DHD.J. Houwing
D.J. Houwing
ARAnouschka Ramsteijn
Anouschka Ramsteijn
IRI.W. Riemersma
I.W. Riemersma
JOJocelien Olivier
Jocelien Olivier
The serotonin transporter (SERT) gene has been linked to depression, especially the short allele of the serotonin transporter linked polymorphic region (5-HTTLPR). When short allele carriers are exposed to stressful life events, their risk for developing depression is increased. The neurochemical properties of the short allele of the 5-HTTLPR in humans can be mimicked in heterozygous serotonin transporter knockout (SERT+/−) rats. These animals have a similar reduction in SERT expression as humans with a 5-HTTLPR short allele. Several stress protocols have been used in SERT+/− animals but behavioural outcomes were mixed. Many studies used males to examine the behavioural effects of stress in SERT+/− rats, ignoring possible effects in females. However, women are depressed twice as often compared to men, therefore it is of great importance to study the effects of stress in females as well. Because early postnatal adversity can contribute to the psychopathology of depression, especially in vulnerable individuals, our aim was to investigate the effects of early-life stress in female SERT+/- rats and determine whether female SERT+/− rats could model the human short allele 5HTTLPR carriers. To this end, SERT+/− rats were maternally separated for six hours a day from postnatal day 2-15. Control rats were handled for 15 min from PND2-15 to control for litter disturbances. In adulthood, female rats were assessed for affective, social and coping behaviour. In addition, nerve growth factor (NGF) gene expression in the basolateral amygdala (BLA) and paraventricular nucleus of the hypothalamus (PVN) and basal plasma corticosterone levels were measured. Results show that maternal separation lowered sucrose preference in female SERT+/− rats compared to control SERT+/− rats, reflecting anhedonic behaviour. In addition, compared to control SERT+/− rats, maternal separation significantly lowered NGF gene expression in SERT+/− rats in both BLA and PVN, but did not affect plasma corticosterone levels. Together, these results show that early-life stress in female SERT+/− rats leads to depression-like behaviour and related plasticity impairments in the BLA and PVN.

11 May 2023 in Nutrition Reviews
Verified
Journal Article
Open access
PDF file
BKBenjamin Momo Kadia
Benjamin Momo Kadia
MOMary Iwaret Otiti
Mary Iwaret Otiti
ARAnouschka Ramsteijn
Anouschka Ramsteijn
DSDoudou Sow
Doudou Sow
BFBabacar Faye
Babacar Faye
SAStephen Allen
Stephen Allen
In children exposed to poor hygiene and sanitation, invasion of the gut by pathogenic microbes can result in a subclinical enteropathy termed “environmental enteric dysfunction” (EED) that contributes to undernutrition, growth faltering, and impaired organ development. EED may already be present by age 6–12 weeks; therefore, interventions that can be started early in life, and used alongside breastfeeding, are needed to prevent or ameliorate EED. A healthy gut microbiota is critical for intestinal development and repair, nutrient digestion and absorption, and resisting colonization or overgrowth by pathogens. However, its development can be impaired by several environmental factors. Dietary supplementation with pro-, pre-, or synbiotics may be a pragmatic and safe means of building the resilience of the developing gut microbiota against adverse environmental factors, thereby preventing EED.

3 August 2024 in Microbial Biotechnology
Verified
Journal Article
Open access
ARAnouschka Ramsteijn
Anouschka Ramsteijn
PLPetra Louis
Petra Louis
The human gut microbiota influences its host via multiple molecular pathways, including immune system interactions, the provision of nutrients and regulation of host physiology. Dietary fibre plays a crucial role in maintaining a healthy microbiota as its primary nutrient and energy source. Industrialisation has led to a massive decrease of habitual fibre intake in recent times, and fibre intakes across the world are below the national recommendations. This goes hand in hand with other factors in industrialised societies that may negatively affect the gut microbiota, such as medication and increased hygiene. Non‐communicable diseases are on the rise in urbanised societies and the optimisation of dietary fibre intake can help to improve global health and prevent disease. Early life interventions shape the developing microbiota to counteract malnutrition, both in the context of industrialised nations with an overabundance of cheap, highly processed foods, as well as in Low‐ and Middle‐Income Countries (LMICs). Adequate fibre intake should, however, be maintained across the life course to promote health. Here we will discuss the current state of dietary fibre research in the global context and consider different intervention approaches.

31 January 2022 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
ARAnouschka Ramsteijn
Anouschka Ramsteijn
RVRikst Nynke Verkaik-Schakel
Rikst Nynke Verkaik-Schakel
DHDanielle J. Houwing
Danielle J. Houwing
TPTorsten Plösch
Torsten Plösch
JOJocelien Olivier
Jocelien Olivier